Page last updated: 2024-12-07
13-hydroxyeicosatetraenoic acid
Description
## 13-Hydroxyeicosatetraenoic Acid (13-HODE)
13-HODE is a **lipid mediator** derived from the **omega-6 fatty acid linoleic acid**. It is produced through the action of **lipoxygenases** (LOXs), specifically **13-lipoxygenase**, on linoleic acid.
**Here's why 13-HODE is important for research:**
**1. Diverse Biological Roles:**
* **Anti-inflammatory effects:** 13-HODE has been shown to suppress inflammation by inhibiting the production of pro-inflammatory cytokines and chemokines. It can also modulate the expression of adhesion molecules involved in inflammatory cell recruitment.
* **Antioxidant activity:** 13-HODE can act as an antioxidant by scavenging free radicals and preventing lipid peroxidation.
* **Wound healing:** 13-HODE promotes wound healing by stimulating cell proliferation and migration.
* **Cardiovascular effects:** 13-HODE can influence blood pressure and platelet aggregation, suggesting potential roles in cardiovascular health.
* **Neuroprotection:** Studies indicate that 13-HODE may protect neurons from damage caused by oxidative stress and excitotoxicity.
**2. Potential Therapeutic Applications:**
* **Anti-inflammatory therapies:** 13-HODE's anti-inflammatory properties could be harnessed to develop novel treatments for inflammatory diseases like arthritis, asthma, and inflammatory bowel disease.
* **Wound healing treatments:** 13-HODE's ability to promote wound healing could lead to the development of topical therapies for burns and other wounds.
* **Neuroprotective agents:** 13-HODE's neuroprotective potential could be explored for the treatment of neurodegenerative diseases like Alzheimer's and Parkinson's.
**3. Research Focus:**
* **Mechanisms of action:** Researchers are investigating the precise mechanisms by which 13-HODE exerts its diverse biological effects.
* **Regulation of 13-HODE production:** Understanding the factors that regulate 13-HODE production could lead to new strategies for manipulating its levels in the body.
* **Role in disease pathology:** Studies are exploring the potential roles of 13-HODE in various diseases and how it may contribute to their development and progression.
**4. Advantages for Research:**
* **Naturally occurring:** 13-HODE is found in various tissues and fluids, making it a readily available compound for research.
* **Stability:** It is relatively stable under physiological conditions, making it easier to study.
* **Accessibility:** There are various methods available for synthesizing and purifying 13-HODE, making it accessible for research purposes.
**Overall, 13-HODE is a fascinating and important molecule with diverse biological roles. Its potential therapeutic applications and the growing body of research focused on its properties make it an exciting area for further investigation.**
13-hydroxyeicosatetraenoic acid: RN refers to ((R)-(all-Z))-isomer; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 132934 |
MeSH ID | M0250581 |
Synonyms (2)
Synonym |
13-hydroxyeicosatetraenoic acid |
13-hydroxyicosa-2,4,6,8-tetraenoic acid |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.58
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.58 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.37 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |